Figures and Tables

Print
Related Pages
Figure or Table Title
A two-column table lising all figures and tables from the guidance document. The first column indicates the table or figure and its associated section in the document. The second column includes the titles of each table or figure along with associated download links of PDF and PowerPoint documents.
Section 1 – General Viral Hepatitis Surveillance Guidance
Table 1-1 National notification and print criteria for hepatitis A, hepatitis B, and hepatitis C
[Download PDF]
Table 1-2 Viral hepatitis conditions with corresponding National Notifiable Diseases Surveillance System event codes and national notification criteria
[Download PDF| PPT]
Table 1-3 Epidemiologic risk behaviors, risk exposures, and groups at risk for hepatitis A, hepatitis B, and hepatitis C
[Download PDF| PPT]
Section 2 – Hepatitis A Surveillance Guidance
Figure 2-1 Typical serologic course of hepatitis A virus infection and recovery
[Download PDF| PPT]
Table 2-1 Interpretation of hepatitis A laboratory results
[Download PDF| PPT]
Table 2-2 CDC/CSTE case definition for hepatitis A, 2019
[Download PDF| PPT]
Figure 2-2 Process for hepatitis A case ascertainment and classification
[Download PDF| PPT]
Section 3 – Hepatitis B Surveillance Guidance
Figure 3-1 Typical serologic course of acute hepatitis B to recovery
[Download PDF| PPT]
Figure 3-2 Typical serologic course of the progression to chronic hepatitis B
[Download PDF| PPT]
Table 3-1 Interpretation of hepatitis B laboratory results
[Download PDF| PPT]
Table 3-2 CDC/CSTE case definition for acute hepatitis B, 2024
[Download PDF]
Table 3-3 CDC/CSTE case definition for chronic hepatitis B, 2024
[Download PDF]
Figure 3-3 Process for classifying cases of hepatitis B as acute and chronic
[Download PDF]
Table 3-4 Considerations for hepatitis B cases who received a solid organ from a donor
[Download PDF]
Table 3-5 CDC/CSTE case definition for perinatal hepatitis B, 2017
[Download PDF| PPT]
Figure 3-4 Process for perinatal hepatitis B case ascertainment and classification
[Download PDF| PPT]
Table 3-6 Common laboratory codes for hepatitis B post-vaccination testing
[Download PDF| PPT]
Section 4 – Hepatitis C Surveillance Guidance
Figure 4-1 Typical serologic course of hepatitis C virus infection
[Download PDF| PPT]
Table 4-1 Interpretation of hepatitis C laboratory results
[Download PDF| PPT]
Table 4-2 CDC/CSTE case definitions for acute and chronic hepatitis C, 2020
[Download PDF| PPT]
Figure 4-2 Process for acute and chronic hepatitis C case ascertainment and classification
[Download PDF| PPT]
Table 4-3 Considerations for hepatitis C cases who were organ (or tissue) transplant recipients
[Download PDF]
Table 4-4 CDC/CSTE case definition for perinatal hepatitis C, 2018
[Download PDF| PPT]
Figure 4-3 Process for perinatal hepatitis C case ascertainment and classification
[Download PDF| PPT]
Section 5 – Additional Information and Resources
Table 5-1 Classification of hepatitis C cases diagnosed concurrently with hepatitis A
[Download PDF| PPT]
Table 5-2 Person and case identification variables in the National Electronic Disease Surveillance System Base System
[Download PDF| PPT]
Table 5-3 Person and case identification variables via Health Level Seven case notification
[Download PDF| PPT]
Table 5-4 Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via the National Electronic Telecommunications System for Surveillance
[Download PDF| PPT]
Table 5-5 Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via the National Electronic Disease Surveillance System Base System
[Download PDF| PPT]
Table 5-6 Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via Health Level Seven case notification
[Download PDF| PPT]
Table 5-7 Selections for variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via Health Level Seven case notification
[Download PDF| PPT]
Table 5-8 Supplementary data sources
[Download PDF| PPT]
Table 5-9 Use of supplementary data sources for case ascertainment, investigation, characterization, and for monitoring of infection trends and disease-related outcomes
[Download PDF| PPT]
Table 5-10 International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes for hepatitis A, hepatitis B, and hepatitis C for clinical diagnosis and cause of death coding
[Download PDF| PPT]
Section 6 – Appendices
Figure 6-1 Testing algorithm for the Ortho VITROS hepatitis B surface antigen initial assay
[Download PDF| PPT]